Linked Life Data

20485502

Source:http://linkedlifedata.com/resource/pubmed/id/20485502

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20485502rdf:typepubmed:Citationlld:pubmed
pubmed-article:20485502lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0332461lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C1517281lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C2346689lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C1550025lld:lifeskim
pubmed-article:20485502lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:20485502pubmed:issue5lld:pubmed
pubmed-article:20485502pubmed:dateCreated2010-5-20lld:pubmed
pubmed-article:20485502pubmed:abstractTextImmunotherapy for Alzheimer's disease (AD) relies on antibodies directed against toxic amyloid-beta peptide (Abeta), which circulate in the bloodstream and remove Abeta from the brain. In mouse models of AD, the administration of anti-Abeta antibodies directly into the brain, in comparison to the bloodstream, was shown to be more efficient at reducing Abeta plaque pathology. Therefore, delivering anti-Abeta antibodies to the brain of AD patients may also improve treatment efficiency. Transcranial focused ultrasound (FUS) is known to transiently-enhance the permeability of the blood-brain barrier (BBB), allowing intravenously administered therapeutics to enter the brain. Our goal was to establish that anti-Abeta antibodies delivered to the brain using magnetic resonance imaging-guided FUS (MRIgFUS) can reduce plaque pathology. To test this, TgCRND8 mice received intravenous injections of MRI and FUS contrast agents, as well as anti-Abeta antibody, BAM-10. MRIgFUS was then applied transcranially. Within minutes, the MRI contrast agent entered the brain, and BAM-10 was later found bound to Abeta plaques in targeted cortical areas. Four days post-treatment, Abeta pathology was significantly reduced in TgCRND8 mice. In conclusion, this is the first report to demonstrate that MRIgFUS delivery of anti-Abeta antibodies provides the combined advantages of using a low dose of antibody and rapidly reducing plaque pathology.lld:pubmed
pubmed-article:20485502pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:languageenglld:pubmed
pubmed-article:20485502pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:citationSubsetIMlld:pubmed
pubmed-article:20485502pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20485502pubmed:statusMEDLINElld:pubmed
pubmed-article:20485502pubmed:issn1932-6203lld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:ChopraRajivRlld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:McLaurinJoAnn...lld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:HynynenKuller...lld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:HuangYuexiYlld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:AubertIsabell...lld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:MarkhamKellyKlld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:JordãoJessica...lld:pubmed
pubmed-article:20485502pubmed:authorpubmed-author:Ayala-GrossoC...lld:pubmed
pubmed-article:20485502pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20485502pubmed:volume5lld:pubmed
pubmed-article:20485502pubmed:ownerNLMlld:pubmed
pubmed-article:20485502pubmed:authorsCompleteYlld:pubmed
pubmed-article:20485502pubmed:paginatione10549lld:pubmed
pubmed-article:20485502pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:meshHeadingpubmed-meshheading:20485502...lld:pubmed
pubmed-article:20485502pubmed:year2010lld:pubmed
pubmed-article:20485502pubmed:articleTitleAntibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.lld:pubmed
pubmed-article:20485502pubmed:affiliationBrain Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.lld:pubmed
pubmed-article:20485502pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20485502pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20485502pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed